$35.58 $0.29 per serving
Product analysis
CoQ10 200 mg supports normal cellular energy production and may help fatigue in some circumstances, although a routine energy boost is uncertain. It offers favourable value for the amount supplied.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The CoQ10 is identified as ubiquinone, but its form quality remains uncertain. That identification does not establish a special delivery advantage.
Ingredient Transparency100
The CoQ10 amount and form are clearly stated. That makes the serving straightforward to compare.
Value For Money100
The CoQ10 is inexpensive for the amount supplied. That comparison makes it a relatively economical option for this ingredient.
Customer Satisfaction90
Customer ratings are very favourable across several thousand reviews. They describe satisfaction without establishing effects on fatigue or heart health.
Product Focus79
CoQ10 has a clear role in cellular energy production, with limited evidence for fatigue and selected cardiovascular markers. Those findings depend on the preparation and population, without establishing routine energy boosts or longer life.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.29
- Also available
CoQ10 100 mg$36.00- Customer rating
- 4.8 · 3,612 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 has limited support for selected blood-pressure, blood-lipid and blood-vessel measures in specific adult populations. Findings are mixed, including a trial with no significant improvement in its main blood-pressure measure. Its declared conventional active amount provides an exposure comparison, without demonstrating a superior delivery method or prevention of cardiovascular events.
How this product is rated for Heart Health
Ingredient fit93
CoQ10 provide the main connection to heart health. The declared active amount reaches the supplied comparison range.
Goal fit
CoQ10 connect the formula to blood-vessel function.
Dose adequacy
The declared active amount reaches the supplied comparison range; more is not automatically associated with greater benefit.
Pathways60
The findings concentrate on blood-vessel function. Coverage remains focused rather than broad.
Depth
The strongest represented route is blood-vessel function, through coq10.
Breadth
Coverage is concentrated on blood-vessel function, with no comparable coverage of the other assessed heart-related routes.
Evidence98
CoQ10 has limited human evidence for selected vascular measures, with mixed results and population-specific findings.
Evidence strength
CoQ10 supplies the strongest evidence contribution here, from limited trials in selected adult populations.
Studied preparation
Declared conventional CoQ10 fits the supplied preparation comparison; finished-product equivalence or delivery superiority is not established.
Formulation logic100
No unmet partner requirement or listed conflict was identified. Amount coverage reflects the ingredients counted in the saved findings.
Partner coverage
The contributing ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No listed stimulant or high-sodium conflict was identified in the supplied facts.
Effective doses
The ingredients counted for amount coverage meet its comparison threshold; this does not prove clinical effectiveness.
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
CoQ10 at 200 mg supports mitochondrial energy and antioxidant processes and meets the saved comparison benchmark. The limited human skin-aging findings concern a particular water-soluble preparation, however, so a larger generic CoQ10 amount does not establish the same benefits or longer life.
How this product is rated for Longevity
Ingredient fit93
The relevant ingredients are a clear focus of the formula. The assessed amounts fully meet the saved comparison benchmarks.
Goal fit
The relevant ingredients are a clear focus of the formula.
Dose adequacy
The assessed amounts fully meet the saved comparison benchmarks.
Pathways40
The strongest assessed area is mitochondrial energy production, with substantial coverage. One assessed area reaches the threshold for substantial coverage.
Depth
The strongest assessed area is mitochondrial energy production, with substantial coverage.
Breadth
One assessed area reaches the threshold for substantial coverage.
Evidence30
Coenzyme Q-10 provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims. The assessed ingredients do not match the recognized trial preparations.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims.
Studied preparation
The assessed ingredients do not match the recognized trial preparations.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 participates in cellular energy production and has limited support for fatigue relief that depends on preparation and population. This serving supplies 200 mg of ubiquinone and meets the saved amount comparison. Clinical fatigue findings do not establish a routine energy boost in healthy adults.
How this product is rated for Energy
Ingredient fit93
Ubiquinone supplies the relevant fatigue-related contribution.
Goal fit
CoQ10 is the sole contributing ingredient.
Dose adequacy
The ubiquinone amount meets the saved comparison, without establishing a guaranteed benefit.
Pathways53
CoQ10 provides the saved connection to mitochondrial energy production, with no broader pathway coverage.
Depth
Mitochondrial energy production is the main pathway finding from ubiquinone.
Breadth
Only mitochondrial energy production reaches the saved coverage threshold.
Evidence84
CoQ10 leads the evidence finding and matches the saved preparation criteria.
Evidence strength
CoQ10 leads the evidence finding and matches the saved preparation criteria..
Studied preparation
The contributing declarations meet the saved preparation criteria; this does not establish superiority of their forms.
Formulation logic100
The included ingredients have no missing required partner or identified conflict in the saved findings.
Partner coverage
No required ingredient partner is missing among the included contributions.
Conflicts
No configured conflict was identified in the supplied findings.
Effective doses
The included ingredients meet the saved minimum amount criterion; this does not establish a guaranteed benefit.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Coenzyme Q-10 has limited support for blood-pressure, lipid and blood-vessel function markers in people with dyslipidemia. This product declares ubiquinone, which fits the general CoQ10 preparation rather than the separately studied ubiquinol form. Its amount can be compared with the reviewed 120 mg daily study exposure, but that comparison does not establish cardiovascular-event prevention or a superior delivery form.
How this product is rated for Cardiovascular Support
Ingredient fit93
The formula is focused on CoQ10 without other counted off-goal actives.
Goal fit
The formula is focused on CoQ10 without other counted off-goal actives.
Dose adequacy
The serving exceeds the reviewed 120 mg CoQ10 anchor, without established proportionately greater benefit.
Pathways60
The saved finding is concentrated in blood-vessel nitric-oxide function.
Depth
The saved finding is concentrated in blood-vessel nitric-oxide function.
Breadth
Only this area reaches the saved coverage reference; the other evaluated areas have no contribution.
Evidence88
CoQ10 leads through limited marker findings in dyslipidemia rather than proven cardiovascular-event prevention.
Evidence strength
CoQ10 leads through limited marker findings in dyslipidemia rather than proven cardiovascular-event prevention.
Studied preparation
The counted preparation satisfies the saved preparation check; this does not extend the supplied findings to other populations or outcomes.
Formulation logic100
The counted ingredients satisfy the partner and amount checks, with no matched configured conflict.
Partner coverage
The counted ingredients were treated as working alone or having their required partners.
Conflicts
The stimulant and high-sodium adjustments are inapplicable because the required ingredients are absent.
Effective doses
All counted ingredients meet the saved amount threshold; that threshold is not proof of clinical effectiveness.
Impact
High effect
Coenzyme Q-10 · 200 mg
Coenzyme Q-10 helps mitochondria transfer electrons during normal cellular energy production. That role does not establish a faster whole-body metabolic rate in adults with adequate nutrition. The supplied studies concern metabolic markers rather than a demonstrated routine increase in energy expenditure, so the declared amount does not establish a metabolism boost.
How this product is rated for Metabolism Support
Ingredient fit93
Coenzyme Q-10 account for the main included ingredient findings. Amount comparisons remain separate from demonstrated increases in energy expenditure.
Goal fit
The included ingredients account for the formula's main connection to the goal, although the product is also linked to other health aims.
Dose adequacy
The included amounts meet the saved comparison anchors; this does not establish a clinically effective metabolic-rate dose.
Pathways54
The strongest recorded connection concerns mitochondrial energy processing; this does not establish increased whole-body energy expenditure.
Depth
The strongest recorded connection concerns mitochondrial energy processing; this does not establish increased whole-body energy expenditure.
Breadth
Only one tracked mechanism reaches the breadth criterion; there is no broad coverage of the other energy-expenditure mechanisms.
Evidence75
Coenzyme Q-10 leads the finding, although mitochondrial and metabolic-marker evidence does not establish routine thermogenesis.
Evidence strength
Coenzyme Q-10 leads the finding, although mitochondrial and metabolic-marker evidence does not establish routine thermogenesis.
Studied preparation
The included ingredients meet the saved preparation criterion; this does not extend their evidence to a persistent metabolic-rate increase.
Formulation logic100
No required partner is missing and no configured conflict was matched. The amount findings do not establish added thermogenic benefit from the formula.
Partner coverage
The included ingredients have their required partners or can contribute independently; no additional thermogenic benefit from combining them is established.
Conflicts
No configured ingredient conflict was matched in the saved findings.
Effective doses
The included ingredients meet the minimum amount criterion; meeting it does not establish a proven thermogenic dose.
Impact
High effect
Coenzyme Q-10 · 200 mg
Ubiquinone CoQ10 has limited relevance to inflammatory markers from a small trial in statin-treated coronary artery disease. TNF-alpha changed, while endpoint CRP and IL-6 did not. This narrow finding does not establish routine clinical anti-inflammatory benefit, and a label serving does not establish the repeated daily study regimen.
How this product is rated for Inflammation
Ingredient fit80
Coenzyme Q-10 provides the main relevant connection. The amount findings are partial rather than a confirmed clinical dose.
Goal fit
Coenzyme Q-10 supplies the main relevant ingredient connection.
Dose adequacy
Known eligible amounts receive partial comparison recognition; unresolved amounts cannot establish an additional dose contribution.
Pathways46
The strongest retained connection concerns oxidative and mitochondrial stress; this identifies a pathway link rather than proven clinical relief.
Depth
The strongest retained connection concerns oxidative and mitochondrial stress; this identifies a pathway link rather than proven clinical relief.
Breadth
One pathway reaches the saved coverage threshold; broader coverage is not established.
Evidence93
Coenzyme Q-10 provides the strongest retained evidence connection, with limited or inconsistent human outcome findings.
Evidence strength
Coenzyme Q-10 provides the strongest retained evidence connection, with limited or inconsistent human outcome findings.
Studied preparation
Eligible material meets the saved preparation criteria; this does not establish clinical benefit from the exact product.
Formulation logic100
No unmet required partner or configured conflict was identified. Meeting amount criteria does not establish added benefit from combining ingredients.
Partner coverage
No unmet required partner was identified for the retained ingredients; their combination does not establish extra benefit.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
Eligible ingredients meet the saved amount threshold; this is not proof of an effective treatment dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q-10 (Ubiquinone) | 200 mg |
Coenzyme Q-10 (Ubiquinone) · 200 mg OverallScore79
Each serving provides 200 mg of CoQ10 as ubiquinone. The estimated cost is about $0.15 per 100 mg of CoQ10, based on the whole-product price.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
Ubiquinone is the identified form of CoQ10; the body converts it to ubiquinol. The saved facts do not record a listed black pepper extract or a specialized delivery claim.
Molecular Form: Ubiquinol vs. Ubiquinone
Ubiquinone is the identified form of CoQ10; the body converts it to ubiquinol.
Formulation & Absorption Enhancers
The saved facts do not record a listed black pepper extract or a specialized delivery claim.
Dose, Safety & Label Transparency100
Each serving supplies 200 mg of CoQ10. The available ingredient information flags none of the additives checked.
Clinical Dosage Alignment
Each serving supplies 200 mg of CoQ10.
Label Transparency & Fillers
The 200 mg amount is stated, and none of the additives checked by the evaluation are flagged in the available ingredient information.
Value100
The estimated cost is about $0.15 per 100 mg of CoQ10, based on the whole-product price.
Price Per Effective Serving
The estimated cost is about $0.15 per 100 mg of CoQ10, based on the whole-product price.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.